RESOLUTION OF AN ONLINE MEETING OF THE SIBERIAN, FAR EASTERN AND SOUTHERN FEDERAL DISTRICTS EXPERTS ON THE RESULTS OF THE EMPEROR-REDUCED TRIAL “THERAPEUTIC APPROACHES IN HEART FAILURE WITH REDUCED EJECTION FRACTION: THE EMPA-REG OUTCOME TRIAL AND THE EMPEROR-REDUCED TRIAL”
At the online meeting of experts held on April 24, 2021, the results of the international multicenter trial EMPEROR-Reduced were considered. Taking into account the beneficial cardiovascular and renal outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction (<40%), and improvement in patient survival rates, a number of proposals and recommendations for widespread implementation of the trial results into practice of treating patients with chronic heart failure were adopted.